Offc Action Outgoing

DS-01

SEED HEALTH, INC.

U.S. Trademark Application Serial No. 88807101 - DS-01 - 10122-11

To: SEED HEALTH, INC. (mtrudell@sheridanross.com)
Subject: U.S. Trademark Application Serial No. 88807101 - DS-01 - 10122-11
Sent: May 08, 2020 03:30:30 PM
Sent As: ecom106@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

Office Action (Official Letter) About Applicant’s Trademark Application

 

U.S. Application Serial No. 88807101

 

Mark:  DS-01

 

 

 

 

Correspondence Address: 

MIRIAM D. TRUDELL

SHERIDAN ROSS P.C.

1560 BROADWAY, SUITE 1200

DENVER, CO 80202

 

 

 

Applicant:  SEED HEALTH, INC.

 

 

 

Reference/Docket No. 10122-11

 

Correspondence Email Address: 

 mtrudell@sheridanross.com

 

 

 

NONFINAL OFFICE ACTION

 

The USPTO must receive applicant’s response to this letter within six months of the issue date below or the application will be abandoned.  Respond using the Trademark Electronic Application System (TEAS).  A link to the appropriate TEAS response form appears at the end of this Office action. 

 

 

Issue date:  May 08, 2020

 

APPLICATION STATUS

 

The referenced application has been reviewed by the assigned trademark examining attorney.  Applicant must respond timely and completely to the issue(s) below.  15 U.S.C. §1062(b); 37 C.F.R. §§2.62(a), 2.65(a); TMEP §§711, 718.03.

 

SEARCH FOR CONFLICTING MARKS

 

The trademark examining attorney searched the USPTO database of registered and pending marks and found no conflicting marks that would bar registration under Trademark Act Section 2(d).  15 U.S.C. §1052(d); TMEP §704.02.

 

IDENTIFICATION OF GOODS

 

Portions of the wording in the identification of goods are indefinite where indicated in bold and italics and must be clarified by specifying the generic name for the goods and/or disease or condition to be prevented or treated or the health goal to be achieved.  See 37 C.F.R. §2.32(a)(6); TMEP §1402.01. 

 

Applicant may substitute the following wording, if accurate: 

 

“Pharmaceutical preparations and substances for {specify disease or condition to be prevented or treated or the health goal to be achieved}; preparations and substances for medical, therapeutic or prophylactic use for {specify disease or condition to be prevented or treated or the health goal to be achieved}; naturopathic, probiotic, and heat-killed microbial preparations and substances for {specify disease or condition to be prevented or treated or the health goal to be achieved}; dietetic preparations and substances preparations adapted for medical purposes; dietary supplements; intravaginal and intrarectal suppositories for {specify disease or condition to be prevented or treated or the health goal to be achieved}; nutritional food additives for medical purposes in the nature of natural food extracts derived from {indicate source of extracts, e.g., fish, meat, vegetables} and {specify, e.g. dietary, nutritional supplements for medical, therapeutic, or prophylactic use; nutrients and nutritional preparations, substances, food additives for human use, namely, {specify goods by generic name} for {medical, therapeutic, or prophylactic use}; probiotic formulations, namely, suppositories and lyophilized powders for medical purposes, in particular, for producing beneficial metabolites, modulating inflammation, increasing beneficial microbes, and inhibiting pathogens in the human microbiome; probiotic and prebiotic formulations, namely, capsules, suppositories, and lyophilized powders for the developing infant gut microbiome, for supporting healthy vaginal microbiomes in pregnant women and supporting healthy breastfeeding, and for increasing strains of beneficial bacteria in infants, children, and adolescents; pharmaceutical preparations for microbiome dysbiosis resulting from the use of antibiotic medications and consumer health interventions for the restoration of balance to a perturbed human microbiome”.

 

Applicant’s goods and/or services may be clarified or limited, but may not be expanded beyond those originally itemized in the application or as acceptably amended.  See 37 C.F.R. §2.71(a); TMEP §1402.06.  Applicant may clarify or limit the identification by inserting qualifying language or deleting items to result in a more specific identification; however, applicant may not substitute different goods and/or services or add goods and/or services not found or encompassed by those in the original application or as acceptably amended.  See TMEP §1402.06(a)-(b).  The scope of the goods and/or services sets the outer limit for any changes to the identification and is generally determined by the ordinary meaning of the wording in the identification.  TMEP §§1402.06(b), 1402.07(a)-(b).  Any acceptable changes to the goods and/or services will further limit scope, and once goods and/or services are deleted, they are not permitted to be reinserted.  TMEP §1402.07(e).

 

For assistance with identifying and classifying goods and services in trademark applications, please see the USPTO’s online searchable U.S. Acceptable Identification of Goods and Services Manual.  See TMEP §1402.04.

 

SIGNIFICANCE OF MARK

 

To permit proper examination of the application, applicant must explain whether the letters and numbers “DS-01” in the mark have any significance in the applicant’s trade or industry or as applied to applicant’s goods and/or services, or if such letters represent a “term of art” within applicant’s industry.  See 37 C.F.R. §2.61(b); TMEP §814.  Failure to comply with a request for information is grounds for refusing registration.  In re Harley, 119 USPQ2d 1755, 1757-58 (TTAB 2016); TMEP §814.

 

ASSISTANCE

 

Please call or email the assigned trademark examining attorney to resolve the issues in this Office action.  Although the USPTO does not accept emails as responses to Office actions, communication by phone or email is permissible to agree to proposed amendments to the application that will immediately place the application in condition for publication, registration, or suspension.  See 37 C.F.R. §2.62(c); TMEP §707.

 

How to respond.  Click to file a response to this nonfinal Office action.    

 

 

/Julie M. Guttadauro/

Julie M. Guttadauro

Examining Attorney

Law Office 106

(571) 272-5875

julie.guttadauro@uspto.gov

 

 

 

RESPONSE GUIDANCE

  • Missing the response deadline to this letter will cause the application to abandon.  A response or notice of appeal must be received by the USPTO before midnight Eastern Time of the last day of the response period.  TEAS and ESTTA maintenance or unforeseen circumstances could affect an applicant’s ability to timely respond.  

 

 

 

U.S. Trademark Application Serial No. 88807101 - DS-01 - 10122-11

To: SEED HEALTH, INC. (mtrudell@sheridanross.com)
Subject: U.S. Trademark Application Serial No. 88807101 - DS-01 - 10122-11
Sent: May 08, 2020 03:30:32 PM
Sent As: ecom106@uspto.gov
Attachments:

United States Patent and Trademark Office (USPTO)

 

USPTO OFFICIAL NOTICE

 

Office Action (Official Letter) has issued

on May 08, 2020 for

U.S. Trademark Application Serial No. 88807101

 

Your trademark application has been reviewed by a trademark examining attorney.  As part of that review, the assigned attorney has issued an official letter that you must respond to by the specified deadline or your application will be abandoned.  Please follow the steps below.

 

(1)  Read the official letter.

 

(2)  Direct questions about the contents of the Office action to the assigned attorney below. 

 

 

/Julie M. Guttadauro/

Julie M. Guttadauro

Examining Attorney

Law Office 106

(571) 272-5875

julie.guttadauro@uspto.gov

 

 

Direct questions about navigating USPTO electronic forms, the USPTO website, the application process, the status of your application, and/or whether there are outstanding deadlines or documents related to your file to the Trademark Assistance Center (TAC).

 

(3)  Respond within 6 months (or earlier, if required in the Office action) from May 08, 2020, using the Trademark Electronic Application System (TEAS).  The response must be received by the USPTO before midnight Eastern Time of the last day of the response period.  See the Office action for more information about how to respond

 

 

 

GENERAL GUIDANCE

·         Check the status of your application periodically in the Trademark Status & Document Retrieval (TSDR) database to avoid missing critical deadlines.

 

·         Update your correspondence email address, if needed, to ensure you receive important USPTO notices about your application.

 

·         Beware of misleading notices sent by private companies about your application.  Private companies not associated with the USPTO use public information available in trademark registrations to mail and email trademark-related offers and notices – most of which require fees.  All official USPTO correspondence will only be emailed from the domain “@uspto.gov.”

 

 

 


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed